Evidence map›Paper›PMID 42908921›Full record

ArticleFrontiers in microbiology2026

Two new sulfur-containing pyridine alkaloids from the co-culture of

Ji-Xin Li, Yu-Shan Gong, Meng-Xue Lu, Hong-Jie Shen, Hao-Xian Lu, Xiu-Juan Zhao, Tian-Peng Yin, Siwen Yuan

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ji-Xin Li *School of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China.
Yu-Shan Gong *School of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China.
Meng-Xue LuSchool of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China.
Hong-Jie ShenSouthern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai, China.
Hao-Xian LuSouthern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai, China.
Xiu-Juan ZhaoSchool of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China.
Tian-Peng YinSchool of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China.
Siwen YuanSchool of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The untapped metabolome of filamentous fungi represents a profound reservoir for therapeutic lead discovery. Although genomic mining confirms an abundance of cryptic biosynthetic gene clusters (BGCs), axenic laboratory culture frequently lacks the ecological stimuli required to trigger their expression, inevitably leading to the redundant isolation of known metabolites. To circumvent this biosynthetic silencing and unlock hidden chemical diversity, strategies such as heterologous expression, the one-strain-many-compounds (OSMAC), epigenetic modulation, and microbial co-cultivation have been increasingly deployed. Herein, we harnessed an interspecies co-cultivation strategy to systematically investigate the biogenetic potential of mangrove-associated fungi belonging to the genus

Indexed as

antifungal activityco-culturegenome miningnatural productssulfur-containing pyridine alkaloids

Identifiers

PMID42908921
PMCPMC13683570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.